A catabolic state in a kidney transplant recipient with COVID-19
Marzuq Billah
Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Search for more papers by this authorAndrew Santeusanio
Department of Pharmacy, Mount Sinai Hospital, New York, NY, USA
Recanati-Miller Transplantation Institute, Mount Sinai Hospital, New York, NY, USA
Search for more papers by this authorVeronica Delaney
Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Recanati-Miller Transplantation Institute, Mount Sinai Hospital, New York, NY, USA
Search for more papers by this authorPaolo Cravedi
Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Search for more papers by this authorCorresponding Author
Samira S. Farouk
Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Recanati-Miller Transplantation Institute, Mount Sinai Hospital, New York, NY, USA
Search for more papers by this authorMarzuq Billah
Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Search for more papers by this authorAndrew Santeusanio
Department of Pharmacy, Mount Sinai Hospital, New York, NY, USA
Recanati-Miller Transplantation Institute, Mount Sinai Hospital, New York, NY, USA
Search for more papers by this authorVeronica Delaney
Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Recanati-Miller Transplantation Institute, Mount Sinai Hospital, New York, NY, USA
Search for more papers by this authorPaolo Cravedi
Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Search for more papers by this authorCorresponding Author
Samira S. Farouk
Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Recanati-Miller Transplantation Institute, Mount Sinai Hospital, New York, NY, USA
Search for more papers by this author
References
- 1Fernández-Cabezón L, Galán B, García JL. New insights on steroid biotechnology. Front Microbiol 2018; 9: 958. https://doi.org/10.3389/fmicb.2018.00958.
- 2Fishman JA, Grossi PA. Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve. Am J Transplant 2020. https://doi.org/10.1111/ajt.15890.
- 3Burgner A, Ikizler TA, Dwyer JP. COVID-19 and the inpatient dialysis unit: managing resources during contingency planning pre-crisis. CJASN 2020; 15: 720. Available from: https://cjasn.asnjournals.org/content/early/2020/04/03/CJN.03750320.
- 4Sanchez EL, Lagunoff M. Viral activation of cellular metabolism. Virology 2015; 479–480: 609.
- 5Denise B, Kevin K, Benjamin K, Widera M. SARS-CoV-2 infected host cell proteomics reveal potential therapy targets. 2020. Available from: https://www.researchsquare.com/article/rs-17218/v1[cited 2020 April 11].
- 6Wu Q, Zhou L, Sun X, et al. Altered Lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep 2017; 7: 1.
